• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

CSA Medical Inc.

CSA Medical wins CE Mark approval for RejuvenAir System

December 4, 2019 By Sean Whooley

CSA Medical announced this week that it won CE Mark approval for its RejuvenAir system for treating chronic obstructive pulmonary disease (COPD) with chronic bronchitis (CB). The RejuvenAir system that is designed to apply spray-liquid nitrogen at -196◦C in a circumferential pattern to central airways through a minimally invasive bronchoscopic procedure, freezing damaged surface area […]

Filed Under: Business/Financial News, Drug-Device Combinations, Regulatory/Compliance, Respiratory Tagged With: CE Mark, CSA Medical Inc.

CSA Medical touts one-year feasibility data for RejuvenAir bronchitis device

October 3, 2019 By Sean Whooley

CSA Medical said today that results of its feasibility study into the RejuvenAir metered cryospray system showed improved quality of life in patients who have chronic obstructive pulmonary disease with chronic bronchitis. The one-year study treated 35 patients using metered cryospray with the RejuvenAir system that is designed to apply spray-liquid nitrogen at -196◦C in […]

Filed Under: Clinical Trials, Drug-Device Combinations, Respiratory Tagged With: CSA Medical Inc.

CSA Medical raises $50m in debt, equity financing rounds

February 8, 2019 By Fink Densford

CSA Medical has raised approximately $50.3 million in separate equity and debt rounds, according to recently posted SEC filings. In its equity funding round, the Lexington, Mass.-based company raised approximately $45.2 million from 37 unnamed sources, with the first sale noted on January 25, 2019. CSA Medical is still looking for $2.5 million in the […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: CSA Medical Inc.

CSA Medical ices $23m funding round

October 9, 2018 By Brad Perriello

CSA Medical said yesterday that it put a $23 million debt-and-equity round on ice for the cryospray technology it’s developing. Boston-based CSA said Horizon Technology Finance led the round with a $15 million loan facility; existing shareholders ponied up $8 million in equity financing, the company said. The round’s first tranche included a $6 million loan from […]

Filed Under: Featured, Funding Roundup, Wall Street Beat Tagged With: CSA Medical Inc.

CSA Medical touts QoL improvements in RejuvenAir chronic bronchitis study

September 19, 2018 By Fink Densford

CSA Medical today released early results from a feasibility study exploring the use of its RejuvenAir Metered Cryospray system in treating patients with chronic bronchitis, touting improvements in quality of life for patients treated with the system. Results from the trial were presented at the 2018 European Respiratory Society Congress in Paris, the Boston-based company said. […]

Filed Under: Clinical Trials, Respiratory Tagged With: CSA Medical Inc.

7 medtech stories we missed this week: Dec. 8, 2017

December 8, 2017 By Danielle Kirsh

From Minimus Spine’s European distribution deal to Stimwave receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Minimus Spine inks EU distribution deal Minimus Spine announced in a Dec. 4 press release that it has signed its first European distribution deal with Italian company Moss […]

Filed Under: 510(k), Cardiovascular, Diagnostics, Food & Drug Administration (FDA), Hospital Care, Pain Management, Regulatory/Compliance, Structural Heart Tagged With: Cagent Vascular, CSA Medical Inc., Dermacon, Elanix, Life Spine Inc., MedTech, Minimus Spine, Stimwave

First patient treated with CSA Medical’s AV spray catheter

October 3, 2017 By Sarah Faulkner

CSA Medical said today that the first patient was treated using the company’s new rapid AV spray catheter for the management of persistent symptomatic esophageal cancer and associated dysplastic Barrett’s disease. The device uses a stainless steel catheter wall to cut the time needed to deliver liquid nitrogen spray to the treatment site by 50%, the […]

Filed Under: Drug-Device Combinations, Oncology, Surgical Tagged With: CSA Medical Inc.

CSA Medical wins another FDA expansion for TruFreeze cryotherapy

August 31, 2017 By Fink Densford

Endoscopic cryo-ablation company CSA Medical said today it won expanded FDA 510(k) clearance for its TruFreeze spray cryotherapy system, now cleared for use on patients with Barrett’s esophagus with low grade dysplasia. With the clearance, the device is now approved for both low and high grade dysplasia as well as malignancies, the Boston-based company said. “Over the […]

Filed Under: 510(k), Food & Drug Administration (FDA), Otolaryngology/Ear, Nose & Throat (ENT), Regulatory/Compliance Tagged With: CSA Medical Inc.

CSA Medical wins expanded FDA nod for TruFreeze system

July 17, 2017 By Fink Densford

Endoscopic cryo-ablation company CSA Medical said today it won FDA 510(k) clearance for a 3rd spray kit, the rapid AV spray kit, for its TruFreeze system. The Boston-based company’s TruFreeze system is designed as a cryosurgical tool designed for use in dermatology, gynecology, general surgery and to ablate benign and malignant lesions. The newly cleared addition is […]

Filed Under: 510(k), Catheters, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: CSA Medical Inc.

Acelity taps Jokinen as CFO, exec VP | Personnel Moves June 20, 2017

June 20, 2017 By Fink Densford

Acelity said last week it tapped Tracy Jokinen as its chief financial officer and executive vice president, taking over for interim CFO Todd Wyatt. Jokinen was formerly a CFO of uniform and facility services provider G&K services, which was acquired by Cintas earlier this year. Prior to working at G&K, Jokinen spent more than 20 years at […]

Filed Under: Business/Financial News Tagged With: Acelity, attunemedical, Avedro Inc., CSA Medical Inc., Delphinus Medical Technologies Inc., Entellus Medical Inc., fireflymedical, mazorrobotics, Medtronic, Personnel Moves, SetPoint Medical, Unilife Corp.

CSA Medical raises $6.6m

July 14, 2015 By Fink Densford

Endoscopic cryo-ablation company CSA Medical has raised $6.6 million in a new financing round, according to an SEC filing. The Baltimore, Md.-based company’s main product is the TruFreeze spray cryotherapy device, designed to deliver super-cold liquid nitrogen via catheter to ablate unwanted tissue, according to CSA. The company’s latest round had 26 unlisted investors, with CSA […]

Filed Under: Business/Financial News, Catheters Tagged With: CSA Medical Inc.

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS